Browse Category

Investment Analysis News 15 December 2025

Amphenol Stock (NYSE: APH) Outlook for Dec. 15, 2025: Dividend Countdown, Q4 Guidance, and Analyst Targets After a Volatile Pullback

Amphenol Stock (NYSE: APH) Outlook for Dec. 15, 2025: Dividend Countdown, Q4 Guidance, and Analyst Targets After a Volatile Pullback

Amphenol Corporation (NYSE: APH) stock is back in focus on December 15, 2025, as investors weigh a sharp late-week selloff, a near-term dividend deadline, and a stream of fresh notes and filings that keep the connector maker in the spotlight heading into year-end. As of 16:41 UTC (11:41 a.m. ET), Amphenol shares were trading around $129.98, up about 0.6% on the day, after ranging between $129.44 and $131.27 in Monday’s session. That modest rebound comes right after a jarring move: APH closed at $129.24 on Friday (Dec. 12) following a steep one-day decline. Insider Monkey+1 The question for investors now
Rivian Stock (RIVN) Today: December 15, 2025 News, Analyst Forecasts, and What Autonomy & AI Means for the Next Move

Rivian Stock (RIVN) Today: December 15, 2025 News, Analyst Forecasts, and What Autonomy & AI Means for the Next Move

Rivian Automotive, Inc. (NASDAQ: RIVN) enters the final full trading weeks of 2025 with its stock hovering near multi-month highs after a volatile reaction to the company’s inaugural Autonomy & AI Day and a rapid-fire round of Wall Street price-target changes. As of Monday, December 15, 2025, Rivian shares were trading around $18.70, up modestly on the day, after touching an intraday high of $19.13 and a low of $18.38. The key question for investors now is whether this rally is the beginning of a durable re-rating—pricing Rivian as a “software-defined vehicle” platform with subscription-like margins—or another short-lived surge in
Vertiv (VRT) Stock News Today, Dec. 15, 2025: AI Data Center Cooling Tailwinds, Analyst Price Targets, and the 2026 Outlook

Vertiv (VRT) Stock News Today, Dec. 15, 2025: AI Data Center Cooling Tailwinds, Analyst Price Targets, and the 2026 Outlook

December 15, 2025 — Vertiv Holdings Co. (NYSE: VRT) is back in the spotlight as investors track the next phase of the AI-driven data center buildout—and the growing infrastructure challenge behind it: power delivery, heat management, and faster deployment timelines. In late-morning U.S. trading on Monday, Vertiv shares hovered around $162, with the company valued at roughly $61 billion. The stock remains well below its 52-week high near $205, a reminder that even the most in-demand “AI picks-and-shovels” names can swing sharply as Wall Street debates how much growth is already priced in. MarketBeat What’s different about today is the
Tesla Stock Jumps on Driverless Robotaxi Testing: TSLA News, Analyst Forecasts, and What Could Move Shares Next

Tesla Stock Jumps on Driverless Robotaxi Testing: TSLA News, Analyst Forecasts, and What Could Move Shares Next

Tesla, Inc. (NASDAQ: TSLA) stock surged on December 15, 2025 as investors latched onto a fresh signal that Tesla’s autonomy roadmap is moving from “promise” to “prototype in public.” Shares climbed roughly 4% in Monday trading, changing hands around $478.87 (up about $19.91 on the day), after CEO Elon Musk confirmed that Tesla is testing robotaxis without a front-seat safety monitor. Reuters The rally pushed TSLA toward levels not seen in months and within striking distance of last year’s record zone. Reuters reported the stock rose as much as 4.9% to $481.37, while noting Tesla’s prior record high of $488.54
Rocket Lab Stock (RKLB) Today: JAXA Launch Success, Neutron “Hungry Hippo” Milestone, Analyst Forecasts, and What Comes Next (Dec. 15, 2025)

Rocket Lab Stock (RKLB) Today: JAXA Launch Success, Neutron “Hungry Hippo” Milestone, Analyst Forecasts, and What Comes Next (Dec. 15, 2025)

Rocket Lab Corporation (NASDAQ: RKLB) is in the spotlight on December 15, 2025, as investors react to a fresh wave of launch news, updated views on the company’s Neutron rocket development timeline, and a stock price that has been highly volatile after a major run-up this year. Early trading painted a split picture: Reuters reported RKLB was up about 2.5% in premarket trading near $63.03 following the weekend’s mission headlines. TradingView MarketWatch’s delayed quote also showed RKLB higher premarket near $62.88 (after a prior close around $61.49). MarketWatch However, by late morning, multiple trackers and commentary outlets pointed to a
Semiconductor Stocks Today: Nvidia Rebounds, Micron and Chip Equipment Rally, While Broadcom and Arm Lag on Fresh Analyst Calls (Dec. 15, 2025)

Semiconductor Stocks Today: Nvidia Rebounds, Micron and Chip Equipment Rally, While Broadcom and Arm Lag on Fresh Analyst Calls (Dec. 15, 2025)

U.S.-listed semiconductor stocks are trying to steady themselves in late-morning trading on Monday, December 15, 2025, after last week’s AI-driven shakeout rattled the “chip trade.” By around 11:30 a.m. ET, the group is splitting into clear winners and losers: AI accelerators and memory names are back in favor, semiconductor equipment makers are surging on upbeat 2026–2027 demand forecasts, and several “old-economy” chip exposures—analog and smartphones—are under pressure following high-profile downgrades. Reuters+1 Semiconductor market snapshot at 11:30 a.m. ET Semiconductor ETFs are modestly higher, signaling stabilization rather than a full-throttle rebound. The VanEck Semiconductor ETF (SMH) and iShares Semiconductor ETF (SOXX) are
UnitedHealth Group (UNH) Stock News Today: December 15, 2025 Headlines, Analyst Forecasts, and What Investors Are Watching Next

UnitedHealth Group (UNH) Stock News Today: December 15, 2025 Headlines, Analyst Forecasts, and What Investors Are Watching Next

UnitedHealth Group Incorporated (NYSE: UNH) is back in the spotlight as 2025 winds down—caught between “defensive” sector rotation, fresh legal headlines, and a fast-approaching earnings and guidance reset that could shape sentiment for 2026. As of 15:27 UTC on Monday, December 15, 2025, UNH stock traded at $337.51, down about 1.27% on the day, after moving between $337.07 and $344.84. Trading volume was about 1.75 million shares at that point in the session. That price action may look routine, but the story underneath isn’t. UnitedHealth is navigating a complicated mix of: Below is a comprehensive roundup of the most current
Amicus Therapeutics (FOLD) Stock News Today: DMX-200 Trial Milestone, 52-Week High Momentum, and Analyst Forecasts (Dec. 15, 2025)

Amicus Therapeutics (FOLD) Stock News Today: DMX-200 Trial Milestone, 52-Week High Momentum, and Analyst Forecasts (Dec. 15, 2025)

Amicus Therapeutics, Inc. (Nasdaq: FOLD) is back on investors’ radar as the rare-disease biotech extends a strong 2025 run—helped by a milestone quarter of GAAP profitability, expanding global launches for its Pompe franchise, and fresh news tied to a Phase 3 kidney-disease program it licensed earlier this year. On Monday, December 15, 2025, Amicus shares traded around $10.93 intraday after opening near $10.55, with the session range pushing into the low $11 area. Below is a detailed look at the latest Amicus Therapeutics stock news, what Wall Street is forecasting, and the key catalysts (and risks) investors are weighing as
Carvana Stock (CVNA) News Today: Argus Initiates “Buy” as S&P 500 Inclusion Nears — Latest Price Targets, Forecasts and Key Risks (Dec. 15, 2025)

Carvana Stock (CVNA) News Today: Argus Initiates “Buy” as S&P 500 Inclusion Nears — Latest Price Targets, Forecasts and Key Risks (Dec. 15, 2025)

Carvana Co. shares traded around $461 on Monday, extending a powerful run that has pushed the online used-car retailer back into the market spotlight just days before its scheduled S&P 500 entry. The fresh catalyst on Dec. 15, 2025: Argus Research initiated coverage with a “Buy” rating and a $500 price target, calling out Carvana’s competitive advantages versus traditional dealerships (selection, pricing, quality, and user experience). TradingView But as Carvana stock approaches (and in some sessions has flirted with) a $100+ billion valuation, the debate is getting sharper: is this the start of a new institutional chapter powered by index
Eli Lilly Stock (LLY) News Today: Retatrutide Breakthrough, Orforglipron FDA Timeline, and Analyst Forecasts on December 15, 2025

Eli Lilly Stock (LLY) News Today: Retatrutide Breakthrough, Orforglipron FDA Timeline, and Analyst Forecasts on December 15, 2025

December 15, 2025 — Eli Lilly and Company (NYSE: LLY) stock is starting the new week in focus as investors weigh a rapid-fire set of catalysts: a headline-grabbing Phase 3 result for next‑generation obesity drug retatrutide, fresh scrutiny around the FDA review timeline for oral GLP‑1 candidate orforglipron, ongoing capacity expansion in the U.S., and a notable analyst price-target tweak hitting the tape today. MarketBeat+3Reuters+3Reuters+3 Below is what’s moving Eli Lilly stock as of 15.12.2025, what the latest forecasts imply, and which risks matter most heading into 2026. Eli Lilly stock price today: where LLY is trading on Dec. 15,
Costco Stock (COST) Today: Roth Downgrade Ignites Valuation Debate as Analysts Split on 2026 Upside

Costco Stock (COST) Today: Roth Downgrade Ignites Valuation Debate as Analysts Split on 2026 Upside

December 15, 2025 — Costco Wholesale Corporation (NASDAQ: COST) stock traded lower on Monday as Wall Street digested a fresh downgrade that zeroed in on a key investor question heading into 2026: Is Costco’s premium valuation still justified if membership and traffic trends cool, even slightly? StockAnalysis As of the latest available trading data, COST changed hands around the mid-$870s, down about 1% on the day, after opening near $883 and dipping as low as the mid-$874s in early trading. StockAnalysis What’s driving Costco stock on December 15, 2025 Roth turns bearish: “Small misses” could trigger a re-rating The most
AMD Stock Outlook (NASDAQ: AMD): Latest News, Analyst Forecasts, and Key Catalysts to Watch on December 15, 2025

AMD Stock Outlook (NASDAQ: AMD): Latest News, Analyst Forecasts, and Key Catalysts to Watch on December 15, 2025

Advanced Micro Devices (AMD) stock is attempting to steady itself on Monday, December 15, after last week’s sharp “AI trade” pullback put renewed focus on valuation, capital spending discipline, and Washington’s shifting rules for advanced chip exports. As of 14:43 UTC today (Dec. 15), AMD shares were at $213.13, up about 1.1% on the session, trading between $210.60 and $214.01 intraday. The backdrop matters: U.S. equity futures pointed higher into the open as investors braced for a data-heavy week that could reshape expectations for interest rates—an important driver for high-multiple tech and semiconductors. Reuters Key takeaways for AMD investors today
1 156 157 158 159 160 282

Stock Market Today

Meta stock faces an AI split: ad gains vs a $135 billion bill

Meta stock faces an AI split: ad gains vs a $135 billion bill

7 February 2026
Meta shares dropped 1.3% to $661.46 on Friday after the company projected 2026 capital spending of up to $135 billion, raising investor concerns over cash flow. Meta reported Q4 revenue of $59.89 billion, up 24% year-over-year, with ad impressions rising 18%. Analysts remain divided on whether AI-driven ad gains can offset the steep spending ramp.
IAG share price jumps toward a 52-week peak — what to watch before London reopens

IAG share price jumps toward a 52-week peak — what to watch before London reopens

7 February 2026
IAG shares rose 4.33% to 438.50 pence Friday, near their 52-week high, ahead of full-year results due later this month. The company reported 162,073,135 treasury shares and total voting rights of 4,565,128,012. Brent crude fell 2.2% Thursday to $67.93 a barrel. South Europe Ground Services logged 712,340 operations in 2025 and seeks approval to operate in Portugal.
Go toTop